Publications

For a complete list of publications, please see my Google Scholar page, PubMed, or ORCID.

Statistical Methodology

  1. Hughes JP, Williamson BD, Krakauer C, Chau G, Ortiz B, Wakefield J, Hendrix C, Amico KR, Holtz TH, Bekker LG, and Grant R. Combining information to estimate adherence in studies of pre-exposure prophylaxis for HIV prevention: application to HPTN 067. Statistics in Medicine, 2022.
  2. Williamson BD, Gilbert PB, Simon NR, and Carone M. A general framework for inference on algorithm-agnostic variable importance. Journal of the American Statistical Association, 2021.
  3. Williamson BD, Hughes JP, and Willis AD. A multi-view model for relative and absolute microbial abundances. Biometrics, 2021.
  4. Williamson BD, Gilbert PB, Carone M, and Simon N. Nonparametric variable importance assessment using machine learning techniques (with discussion). Biometrics, 2020.
  5. Williamson BD, Gilbert PB, Carone M, and Simon N. Rejoinder to “Nonparametric variable importance assessment using machine learning techniques”. Biometrics, 2020.
  6. Williamson BD and Feng J. Efficient nonparametric statistical inference on population feature importance using Shapley values. Proceedings of the 37th International Conference on Machine Learning, 2020.
  7. Hanscom B, Hughes JP, Williamson BD, and Donnel D. Adaptive non-inferiority margins under observable non-constancy. Statistical Methods in Medical Research, 2018.
  8. Feng J, Williamson BD, Carone M, and Simon N. Nonparametric variable importance using an augmented neural network with multi-task learning. Proceedings of the 35th International Conference on Machine Learning, 2018.
  9. Anchang B, Davis KL, Fienberg H, Williamson B, Bendall SC, Karacosta L, Tibshirani R, Nolan GP, and Plevritis SK. DRUG-NEM: optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences, 2018.

Collaborative Science

  1. Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O’Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi N, Huynh C, Miller J, El Sahly HN, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA, Immune Assays Team, Moderna Inc. Team, Coronavirus Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team, and United States Government (USG)/CoVPN Biostatistics Team (incl. Williamson BD). Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science, 2021.
  2. Han S, Williamson BD, and Fong Y. Improving random forest predictions in small datasets from two-phase sampling designs. BMC Medical Informatics and Decision Making, 2021.
  3. Huang Y, Williamson BD, Moodie Z, Carpp LN, Chambonneau L, DiazGranados CA, and Gilbert PB. Analysis of neutralizing antibodies as a correlate of instantaneous risk of hospitalized dengue in placebo recipients of dengue vaccine efficacy trials. The Journal of Infectious Diseases, 2021.
  4. Williamson BD, Magaret CA, Gilbert PB, Nizam S, Simmons C, and Benkeser D. Super LeArner Prediction of NAb Panels (SLAPNAP): a containerized tool for predicting combination monoclonal broadly neutralizing antibody sensitivity. Bioinformatics, 2021.
  5. Duke ER, Williamson BD, Borate B, Golob JL, Wychera C, Stevens-Ayers T, Huang M-L, Cossrow N, Wan H, Mast CT, Marks MA, Flowers ME, Jerome KR, Corey L, Gilbert PB, Schiffer JT, and Boeckh MJ. Cytomegalovirus viral load kinetics as surrogate endpoints after allogeneic transplantation. The Journal of Clinical Investigation, 2020.
  6. Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, Feely F, Pyo CW, Ferrari G, Frank I, Karuna ST, Swann E, Mascola J, Graham BS, Hammer SM, Sobieszczyk ME, Corey L, Janes H, McElrath MJ, Gottardo R, Gilbert PB, and Tomaras GD. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation, 2019.
  7. Magaret CA, Benkeser DC, Williamson BDD, Borate BR, Carpp LN, Georgiev IS, Setliff I, Dingens AS, Simon N, Carone M, Simpkins C, Montefiori D, Alter G, Yu WH, Juraska M, Edlefsen PT, Karuna S, Mgodi NM, Edugupanti S, and Gilbert BP. Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 features. PLOS Computational Biology, 2019.
  8. Safren SA, Hughes JP, Mimiaga MJ, Moore AT, Friedman RK, Srithanaviboonchai K, Limbada M, Williamson BD, Elharrar V, Cummings V, Magidson JF, Gaydos CA, Celentano D, and Mayer KH for the HPTN063 Study Team. Frequency and predictors of estimated HIV transmissions and bacterial STI acquisition among HIV-positive patients in HIV care across three continents. Journal of the International AIDS Society, 2016.
  9. Ritchwood TD, Hughes JP, Jennings L, MacPhail C, Williamson B, Selin A, Kahn K, Gomes-Olive XF, and Pettifor A. Characteristics of age-discordant partnerships associated with HIV risk among young South African women (HPTN 068). Journal of Acquired Immune Deficiency Syndromes, 2016.